↓ Skip to main content

Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival

Overview of attention for article published in Annals of Surgical Oncology, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
1 policy source
twitter
10 X users

Citations

dimensions_citation
124 Dimensions

Readers on

mendeley
86 Mendeley
Title
Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
Published in
Annals of Surgical Oncology, January 2014
DOI 10.1245/s10434-014-3486-z
Pubmed ID
Authors

J. Bart Rose, Flavio G. Rocha, Adnan Alseidi, Thomas Biehl, Ravi Moonka, John A. Ryan, Bruce Lin, Vincent Picozzi, Scott Helton

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 84 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 16%
Other 11 13%
Student > Postgraduate 9 10%
Student > Master 8 9%
Student > Bachelor 7 8%
Other 18 21%
Unknown 19 22%
Readers by discipline Count As %
Medicine and Dentistry 51 59%
Agricultural and Biological Sciences 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Psychology 2 2%
Immunology and Microbiology 1 1%
Other 4 5%
Unknown 24 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2023.
All research outputs
#4,261,000
of 24,211,034 outputs
Outputs from Annals of Surgical Oncology
#1,253
of 6,797 outputs
Outputs of similar age
#49,515
of 317,602 outputs
Outputs of similar age from Annals of Surgical Oncology
#9
of 88 outputs
Altmetric has tracked 24,211,034 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,797 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.